The Lab’s overall goal is to study driver genetic and epigenetic events, and immuno-modulatory molecules, dissect the functional impact and translate information learned in basic biology into clinical decision-making. The Lab has a special interest in early lesions such as precursor melanocytic nevi and early stage melanomas of the skin.
The Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
1470 Madison Avenue
New York, NY 10029